Guillaume Blivet, Chief Innovation Officer at REGEnLIFE, presented at the Mass General Hospital, Brain PBM Clinic Rounds (12.08.23) on their preclinical and clinical studies assessing Transcranial and Gut Photobiomodulation as a treatment for Alzheimer’s Disease.